Literature DB >> 30650068

Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver.

Yukinori Tanoue1,2, Atsushi Nanashima1, Koichi Yano1, Yoshirou Fujii1, Masahide Hiyoshi1, Naoya Imamura1, Takeomi Hamada1, Makoto Ikenoue1, Takashi Wada1, Yoichi Mizutani3, Toshinori Hirai3.   

Abstract

BACKGROUND: The relationship between posthepatectomy complications and liver functional parameters was preliminary reported in a pilot study. The present study sequentially evaluated the clinical significance of maximal removal rate of technetium-99m-galactosyl human serum albumin (GSARmax) in the future remnant liver (rGSARmax) in patients to predict posthepatectomy complications.
METHODS: Between 2010 and August 2017, GSARmax, rGSARmax, their difference (Dif), and the rGSARmax to GSARmax ratio were examined in 247 additional patients who underwent hepatectomy for liver and biliary diseases. Hepatectomy-related postoperative complications (i.e. long-term ascites, intra-abdominal infection, and hepatic failure) occurred in 73 (29.6%) patients.
RESULTS: The median and mean preoperative GSARmax values were 0.477 and 0.498±0.166 mg/min, respectively; rGSARmax values were 0.341 and 0.366±0.145 mg/min, respectively; Dif values were 0.105 and 0.132±0.111 mg/min, respectively; and the rGSARmax to GSARmax ratio values were 0.774 and 0.746±0.177, respectively. Among these, the GSARmax and rGSARmax values were significantly correlated with the liver functional parameters ICGR15, LHL15, HH15, prothrombin activity, serum hyaluronic acid level, and platelet count (all P<0.01). The rGSARmax values were significantly lower in patients with long-term ascites (P<0.05), and the predictive cutoff values of rGSARmax were 0.290 mg/min; however, the multivariate logistic regression analysis showed that rGSARmax was not independently related to long-term ascites.
CONCLUSION: When accompanied by other functional liver reserve parameters, rGSARmax seemed to be an alternative liver functional parameter related to ascites.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30650068      PMCID: PMC6749962          DOI: 10.1097/MNM.0000000000000950

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  25 in total

1.  Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients.

Authors:  A W Hemming; C H Scudamore; C R Shackleton; M Pudek; S R Erb
Journal:  Am J Surg       Date:  1992-05       Impact factor: 2.565

2.  Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization.

Authors:  Yoshihiro Sakamoto; Kazuaki Shimada; Satoshi Nara; Minoru Esaki; Takahiro Kajiwara; Yasuaki Arai; Tsuyoshi Sano; Junji Yamamoto; Tomoo Kosuge
Journal:  Hepatogastroenterology       Date:  2010 Jan-Feb

3.  Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function.

Authors:  Atsushi Nanashima; Syuuichi Tobinaga; Takafumi Abo; Takashi Nonaka; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  J Hepatobiliary Pancreat Sci       Date:  2010-04-09       Impact factor: 7.027

4.  Perioperative non-tumorous factors associated with survival in HCC patients who underwent hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Keiko Hamasaki; Kouki Wakata; Tetsuro Tominaga; Shigekazu Hidaka; Hiroaki Takeshita; Takeshi Nagayasu
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

5.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy.

Authors:  A H Kwon; S K Ha-Kawa; S Uetsuji; T Inoue; Y Matsui; Y Kamiyama
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

7.  HA/GSA-Rmax ratio as a predictor of postoperative liver failure.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Morihiko Ishizaki; Kosuke Matsui; Takamichi Saito; A-Hon Kwon; Yasuo Kamiyama
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

8.  Predictors of intraoperative blood loss in patients undergoing hepatectomy.

Authors:  Atsushi Nanashima; Takafumi Abo; Keiko Hamasaki; Kouki Wakata; Masaki Kunizaki; Kazuo Tou; Hiroaki Takeshita; Shigekazu Hidaka; Terumitsu Sawai; Tomoshi Tsuchiya; Takeshi Nagayasu
Journal:  Surg Today       Date:  2012-10-20       Impact factor: 2.549

9.  Predetermining postoperative hepatic function for hepatectomies.

Authors:  T Takasaki; S Kobayashi; S Suzuki; H Muto; M Marada; Y Yamana; T Nagaoka
Journal:  Int Surg       Date:  1980 Jul-Aug

10.  Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome.

Authors:  Atsushi Nanashima; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Noboru Ide; Hiroaki Takeshita; Terumitsu Sawai; Tohru Nakagoe; Takeshi Nagayasu; Youji Ogawa
Journal:  Hepatol Res       Date:  2004-04       Impact factor: 4.288

View more
  2 in total

1.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

2.  Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors.

Authors:  Kana Yamazaki; Ryuichi Nishii; Yoichi Mizutani; Hirokazu Makishima; Takashi Kaneko; Yoshiharu Isobe; Tamasa Terada; Kentaro Tamura; Etsuko Imabayashi; Toshiaki Tani; Masato Kobayashi; Masaru Wakatsuki; Hiroshi Tsuji; Tatsuya Higashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10-04       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.